<VariationArchive VariationID="1458811" VariationName="NM_003850.3(SUCLA2):c.251dup (p.Tyr84Ter)" VariationType="Duplication" Accession="VCV001458811" Version="4" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-03-05" DateCreated="2022-03-28" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1491159" VariationID="1458811">
      <GeneList>
        <Gene Symbol="SUCLA2" FullName="succinate-CoA ligase ADP-forming subunit beta" GeneID="8803" HGNC_ID="HGNC:11448" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>13q14.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="13" Accession="NC_000013.11" start="47942656" stop="48001273" display_start="47942656" display_stop="48001273" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" start="48516790" stop="48575461" display_start="48516790" display_stop="48575461" Strand="-" />
          </Location>
          <OMIM>603921</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_003850.3(SUCLA2):c.251dup (p.Tyr84Ter)</Name>
      <CanonicalSPDI>NC_000013.11:47996862:T:TT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>13q14.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="13" Accession="NC_000013.11" start="47996862" stop="47996863" display_start="47996862" display_stop="47996863" variantLength="1" positionVCF="47996862" referenceAlleleVCF="A" alternateAlleleVCF="AT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" start="48570997" stop="48570998" display_start="48570997" display_stop="48570998" variantLength="1" positionVCF="48570997" referenceAlleleVCF="A" alternateAlleleVCF="AT" />
      </Location>
      <ProteinChange>Y84*</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000013.10" sequenceAccession="NC_000013" sequenceVersion="10" change="g.48570998dup" Assembly="GRCh37">
            <Expression>NC_000013.10:g.48570998dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000013.11" sequenceAccession="NC_000013" sequenceVersion="11" change="g.47996863dup" Assembly="GRCh38">
            <Expression>NC_000013.11:g.47996863dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008241.1" sequenceAccession="NG_008241" sequenceVersion="1" change="g.9465dup">
            <Expression>NG_008241.1:g.9465dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003850.3" sequenceAccession="NM_003850" sequenceVersion="3" change="c.251dup" MANESelect="true">
            <Expression>NM_003850.3:c.251dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003841.1" sequenceAccession="NP_003841" sequenceVersion="1" change="p.Tyr84Ter">
            <Expression>NP_003841.1:p.Tyr84Ter</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1309421397" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00000" Source="The Genome Aggregation Database (gnomAD), exomes" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_003850.3(SUCLA2):c.251dup (p.Tyr84Ter) AND Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria" Accession="RCV001975069" Version="3">
        <ClassifiedConditionList TraitSetID="6286">
          <ClassifiedCondition DB="MedGen" ID="C2749864">Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-12-10" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-10" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-03-28" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">15877282</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17301081</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="6286" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5549" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Encephalomyopathy</ElementValue>
                <XRef ID="Encephalomyopathy/2524" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mitochondrial encephalomyopathy aminoacidopathy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM, WITH OR WITHOUT METHYLMALONIC ACIDURIA, AUTOSOMAL RECESSIVE, SUCLA2-RELATED</ElementValue>
                <XRef Type="MIM" ID="612073" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria</ElementValue>
                <XRef ID="MONDO:0012791" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MTDPS5</ElementValue>
                <XRef Type="MIM" ID="612073" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">SUCLA2-Related Mitochondrial DNA Depletion Syndrome, Encephalomyopathic Form, with Mild Methylmalonic Aciduria</Attribute>
                <XRef ID="NBK6803" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3681" />
                <XRef ID="3681" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">SUCLA2-Related Mitochondrial DNA Depletion Syndrome, Encephalomyopathic Form with Methylmalonic Aciduria</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">SUCLA2-related mitochondrial DNA (mtDNA) depletion syndrome, encephalomyopathic form with methylmalonic aciduria is characterized by onset of the following features in infancy or childhood (median age of onset 2 months; range of onset birth to 6 years): psychomotor retardation, hypotonia, dystonia, muscular atrophy, sensorineural hearing impairment, postnatal growth retardation, and feeding difficulties. Other less frequent features include distinctive facial features, contractures, kyphoscoliosis, gastroesophageal reflux, ptosis, choreoathetosis, ophthalmoplegia, and epilepsy (infantile spasms or generalized convulsions). The median survival is 20 years; approximately 30% of affected individuals succumb during childhood. Affected individuals may have hyperintensities in the basal ganglia, cerebral atrophy, and leukoencephalopathy on head MRI. Elevation of methylmalonic acid (MMA) in the urine and plasma is found in a vast majority of affected individuals, although at levels that are far below those typically seen in individuals with classic methylmalonic aciduria.</Attribute>
                <XRef ID="NBK6803" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301762</ID>
                <ID Source="BookShelf">NBK6803</ID>
              </Citation>
              <XRef ID="1933" DB="Orphanet" />
              <XRef ID="C2749864" DB="MedGen" />
              <XRef ID="MONDO:0012791" DB="MONDO" />
              <XRef Type="MIM" ID="612073" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4263821" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="10087535|MedGen:C2749864" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002244457" DateUpdated="2024-02-28" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15877282</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17301081</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Tyr84*) in the SUCLA2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SUCLA2 are known to be pathogenic (PMID: 15877282, 17301081). This variant is present in population databases (no rsID available, gnomAD 0.0009%). This variant has not been reported in the literature in individuals affected with SUCLA2-related conditions. ClinVar contains an entry for this variant (Variation ID: 1458811). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SUCLA2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000013.10:g.48570997_48570998insT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C2749864" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200269</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4263821" TraitType="Disease" MappingType="XRef" MappingValue="C2749864" MappingRef="MedGen">
        <MedGen CUI="C2749864" Name="Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

